Roxadustat for heart and nutrition in dialysis patients
Treatments studied
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether roxadustat can help improve heart health, nutrition, and reduce inflammation in people on hemodialysis. It may offer a new treatment option for anemia related to kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been on dialysis for more than 3 months.
- You are not pregnant or breastfeeding.
- You do not have cancer, a blood disorder, or another cause of anemia besides kidney disease.
- You do not have severe heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
This trial is for people with heart failure, chronic kidney disease, and low red blood cell counts (anemia). It examines how well the drug roxadustat helps over a long period by looking at medical records from people who have already taken it for more than a year.
This trial tests whether roxadustat can improve kidney oxygen levels and anemia in people with diabetic kidney disease. It may help if you have anemia from kidney problems and are being considered for medicines like erythropoietin (EPO).
This study tests roxadustat, a medicine that helps the body make more red blood cells, in children and teens with anemia caused by chronic kidney disease. It may help improve anemia and related blood counts, while also monitoring safety.
This trial tests whether a drug called roxadustat can help treat muscle loss (sarcopenia) in people on hemodialysis. It aims to see if improving anemia also strengthens muscles.
Hear when a new Kidney Failure, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.